SCHEMBL4648144

SCHEMBL4648144

CC(C)c1ccc(NC(=O)C=CSc2ccccc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.64
RAB9A P51151 3/20 0.47
CRHBP P24387 1/20 0.47
CRHR2 Q13324 1/20 0.47
NPC1 O15118 3/20 0.46
ALDH1A1 P00352 5/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
LMNA P02545 3/20 0.45
MAPT P10636 3/20 0.45
NPSR1 Q6W5P4 2/20 0.45
PLIN1 O60240 1/20 0.45
HPGD P15428 1/20 0.45
HTT P42858 1/20 0.45
PLIN5 Q00G26 1/20 0.45
ABHD5 Q8WTS1 1/20 0.45
EPHX1 P07099 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9989205 1.00 EGFR (0.64) EGFRRAB9ACRHBPCRHR2NPC1
SCHEMBL9277123 0.85 MAPT (0.56) EGFRRAB9ANPC1ALDH1A1CYP1A2
SCHEMBL3986444 0.85 MAPT (0.56) EGFRRAB9ANPC1ALDH1A1CYP1A2
SCHEMBL4648073 0.85 MAPT (0.56) EGFRRAB9ANPC1ALDH1A1CYP1A2
SCHEMBL3035626 0.84 MMP1 (0.61) EGFRRAB9ANPC1ALDH1A1LMNA
SCHEMBL4644727 0.84 MAPT (0.61) EGFRRAB9ANPC1ALDH1A1CYP3A4
SCHEMBL3035627 0.84 MMP1 (0.61) EGFRRAB9ANPC1ALDH1A1LMNA
SCHEMBL3040573 0.82 ALDH1A1 (0.64) EGFRRAB9ANPC1ALDH1A1LMNA
SCHEMBL4647289 0.81 MMP1 (0.61) EGFRRAB9ANPC1ALDH1A1LMNA
SCHEMBL4646465 0.81 MAOA (0.51) EGFRRAB9ANPC1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8410316-B2 Iminopropene compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-04-02 US disclosed
US-20110319437-A1 IMINOPROPENE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-12-29 US disclosed
EP-1957459-A2 IMINOPROPENE COMPOUND AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-08-20 EP disclosed
WO-2007063702-A2 IMINOPROPENE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-06-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319437-A1 IMINOPROPENE COMPOUND AND USE THEREOF IMPA1, INPP5A, CTRL EGFR 4862/4885RAB9A 941/4885CRHBP 958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.